Evidence map›Paper›PMID 35079137›Full record

ArticleScientific reports2022

Author Correction: Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19.

Yamilé López-Hernández, Joel Monárrez-Espino, Ana-Sofía Herrera-van Oostdam, Julio Enrique Castañeda Delgado, Lun Zhang, Jiamin Zheng, Juan José Oropeza Valdez, Rupasri Mandal, Fátima de Lourdes Ochoa González, Juan Carlos Borrego Moreno and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Yamilé López-HernándezCátedras-CONACyT, Consejo Nacional de Ciencia y Tecnologia, 03940, Mexico, Mexico. ylopezher@conacyt.mx.
Joel Monárrez-EspinoChristus Muguerza Hospital Chihuahua-University of Monterrey, 31000, Chihuahua, Mexico. jmonarrez@hotmail.com.
Ana-Sofía Herrera-van OostdamFaculty of Medicine, Autonomous University of San Luis Potosí, 78210, San Luis Potosi, Mexico.
Julio Enrique Castañeda DelgadoCátedras-CONACyT, Consejo Nacional de Ciencia y Tecnologia, 03940, Mexico, Mexico.
Lun ZhangThe Metabolomics Innovation Center, University of Alberta, Edmonton, AB, T6G1C9, Canada.
Jiamin ZhengThe Metabolomics Innovation Center, University of Alberta, Edmonton, AB, T6G1C9, Canada.
Juan José Oropeza ValdezUnidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social, 98000, Zacatecas, Mexico.
Rupasri MandalThe Metabolomics Innovation Center, University of Alberta, Edmonton, AB, T6G1C9, Canada.
Fátima de Lourdes Ochoa GonzálezUnidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social, 98000, Zacatecas, Mexico.
Juan Carlos Borrego MorenoDepartmento de Epidemiología, Hospital General de Zona #1 "Emilio Varela Luján", Instituto Mexicano del Seguro Social, 98000, Zacatecas, Mexico.
Flor M Trejo-MedinillaAutonomous University of Zacatecas, 98000, Zacatecas, Mexico.
Jesús Adrián LópezMicroRNAs Laboratory, Academic Unit for Biological Sciences, Autonomous University of Zacatecas, 98000, Zacatecas, Mexico.
José Antonio Enciso MorenoUnidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social, 98000, Zacatecas, Mexico.
David S WishartThe Metabolomics Innovation Center, University of Alberta, Edmonton, AB, T6G1C9, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35079137
PMCPMC8788903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.